Table 3.
Characteristics of the 14 patients with confirmed COVID-19.
| Condition (Number, % of Overall) | Median Time from Symptom Onset in Days (IQR) | Hospitalization (% of the Group) | Clinical/Radiological Lung Involvement (% of the Group) | ARDS (% of the Group) | Full Recovery (% of the Group) | Improved (% of the Group) | Stable (% of the Group) | Worsened (% of the Group) | Death (% of the Group) |
|---|---|---|---|---|---|---|---|---|---|
| RMDs (0, 0) | - | - | - | - | - | - | - | - | - |
| Lung Tx (3, 21) | 15 (10-18) | 2 (67) | 2 (67) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Heart Tx (5, 36) | 12 (10-15) | 5 (100) | 2(40) | 0 (0) | 3 (60) | 0 (0) | 0 (0) | 0 (0) | 2 (40) |
| Kidney Tx (6, 43) | 12.5 (10-15) | 5 (80) | 5 (83) | 0 (0) | 5 (80) | 1 (20) | 0 (0) | 0 (0) | 0 (0) |
| Overall (14, 100) | 13.5 (10-15) | 12 (86) | 9 (64) | 0 (0) | 11 (79) | 1 (7) | 0 (0) | 0 (0) | 2 (14) |
COVID-19: coronavirus disease 2019; RMDs: rheumatic diseases; Tx: transplantation; ARDS: acute respiratory distress syndrome.